WCG

Intrinsic Imaging is a full-service medical imaging core lab that offers a range of comprehensive services to support Phase I-IV clinical trials and medical device trials across all classifications. The company employs over 70 full-time, board-certified, fellowship-trained radiologists, supplemented by approximately 100 consulting radiologists and key opinion leaders, all specializing in various therapeutic areas. These areas include cardiovascular, metabolic and pulmonary, gastrointestinal, genitourinary, musculoskeletal, neuroradiology, oncology, and interventional medical devices. Additionally, Intrinsic Imaging leverages advanced technology, including artificial intelligence software, to enhance its service offerings. With its extensive medical expertise and operational capabilities, the company is positioned to deliver exceptional imaging services globally.

The Avoca Group is a consulting firm in the Life Sciences industry that provides tech-enabled services focused on improving quality and compliance in clinical trial execution. The company has recently launched the Diligent® Qualification Platform, a cloud-based technology and suite of services designed to streamline and improve processes for provider qualification. In 2012, Avoca formed the Avoca Quality Consortium®, (AQC). The AQC® is a member-based, pre-competitive collaborative comprised of clinical operations, quality, and outsourcing professionals from pharma, biotech, CROs, and clinical service providers. The AQC was founded based on a commitment to improve quality, drive efficiency and mitigate risk in clinical trial execution. Each Member organization receives company-wide access to a comprehensive and proprietary Knowledge Center of over 400 leading practices, guidelines, tools, templates, and process documents, as well as AQC research and archived webinars. Avoca provides bespoke consulting services focused on Inspection Readiness, Quality Management, Effective Oversight and other areas aligned with ensuring high quality, a mitigation of risk and compliance with international regulations for clinical trial execution. The company’s mission is to have a positive impact on all clinical trials. Our intent is to drive efficiency, shorten cycle times, and improve the clinical research process so that medicines can reach patients faster. To learn more about The Avoca Group, the Avoca Quality Consortium, or to join one of our free monthly Webinars, visit us at www.theavocagroup.com. The Avoca Group is certified by the Women’s Business Enterprise National Council (WBENC).

Trifecta Clinical is a global leader in clinical trial technology solutions, serving pharmaceutical, biotech, and clinical research organizations. With decades of experience, the company offers a fully integrated platform that enhances training, safety, and communication for clinical trials of varying sizes. Trifecta's clinical qualifications management system enables clients to effectively communicate and track essential training and documentation, thereby ensuring inspection readiness and improving the overall conduct of clinical trials. By streamlining study start-up processes and organizing critical training information, Trifecta Clinical supports its partners in achieving their research objectives more efficiently.

Analgesic Solutions LLC, based in Wayland, Massachusetts, specializes in risk mitigation services for clinical trials. Founded in 2002 and now a subsidiary of WIRB-Copernicus Group, Inc., the company focuses on identifying and addressing both random and systematic errors that can adversely affect trial outcomes. It provides consulting services, innovative tools, data science solutions, and training to help research sponsors improve protocol design and development, navigate regulatory submissions, and enhance data reliability. By optimizing the signal-to-noise ratio in clinical data, Analgesic Solutions aims to proactively safeguard the integrity of study results, thereby reducing the likelihood of negative trial outcomes.

ConsentNow enables healthcare, pharmaceutical, and medical device companies to share important information with patients during the informed consent process in a format that is both easy-to-use and easy-to-understand. The technology employs custom video and animation segments to educate patients and online knowledge assessment questions to determine their level of understanding. This multimedia experience is delivered directly to the patient using a tablet device at the clinical site.

FDAnews is a leading provider of regulatory, legislative, and business news tailored to industries governed by the U.S. Food and Drug Administration. Established in 1972 and based in Falls Church, Virginia, the company delivers essential information through various formats, including print and electronic newsletters, books, special reports, training programs, webinars, and conferences. Professionals in the pharmaceutical and medical device sectors rely on FDAnews to navigate the complex and evolving landscape of FDA regulations, ensuring compliance and expediting the market entry of their products. As of 2017, FDAnews operates as a subsidiary of CenterWatch, LLC, further enhancing its capacity to serve the life sciences community.

MedAvante, Inc. specializes in technology-enabled signal detection solutions for clinical trials targeting central nervous system disorders on a global scale. The company offers various services, including the Virgil Investigative Study Platform for site-based assessments and MedAvante Central Ratings, which facilitates live assessments conducted by remote clinicians. Additionally, MedAvante provides scientific risk reduction services such as rater qualification and training, central review for monitoring assessments, and remote ratings to mitigate bias and variability in trial results. Founded in 2002 and based in Hamilton, New Jersey, MedAvante has established a reputation for delivering standardized and expert central raters who conduct live interviews with trial participants via videoconferencing or telephone, contributing to successful outcomes in numerous global trials. MedAvante operates as a subsidiary of WIRB - Copernicus Group, Inc.

ProPhase, LLC is a provider of clinical trial services and specialty solutions focused on enhancing the measurement and analysis of behavioral endpoints. Founded in 2007 and based in New York, the company offers a range of services including electronic data collection using devices such as tablets and wearables, rater training and certification, and study start-up support. ProPhase specializes in developing new outcome measures, calibrating real-world outcomes, and mitigating placebo responses to improve the validity of patient-reported outcomes. The company's expertise extends across various therapeutic areas and phases of clinical trials, aiming to optimize procedures and enhance the overall success of medical studies. As of 2017, ProPhase operates as a subsidiary of the WIRB - Copernicus Group, Inc.

ThreeWire, Inc. specializes in customized clinical trial recruitment, enrollment, and retention services for the pharmaceutical, biotech, and medical device industries. Founded in 1999 and headquartered in Eden Prairie, Minnesota, the company employs a patient-focused approach to streamline the recruitment process, connecting potential participants to clinical sites effectively. In addition to recruitment services, ThreeWire offers direct-to-patient marketing for medical device companies, performance-based pricing, program management, site support, and various digital marketing services, including media planning and social media advertising. The company also provides tools such as MyPatient, an enrollment management application, and the Patient Interaction Center to assist with patient screening and follow-up. As of May 2017, ThreeWire operates as a subsidiary of WIRB - Copernicus Group, Inc.

CenterWatch, LLC provides clinical trials information (news, directories, proprietary market research, and analysis) for clinical research professionals and patients via its online database. It offers drug information and patient resources. The company was founded in 1994 and is based in Boston, Massachusetts. As of June 22, 2016, CenterWatch, LLC operates as a subsidiary of WIRB - Copernicus Group, Inc.